Longest Follow-Up for ICI Plus TKI Favours Treatment with Avelumab Plus Axitinib Combination versus Sunitinib in Patients with Advanced RCC By Ogkologos - February 11, 2025 954 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a final analysis of the JAVELIN Renal 101 study Source RELATED ARTICLESMORE FROM AUTHOR Comprehensive Genomic Profiling with Subsequent Molecularly Guided Therapy Improves Outcomes Over Platinum-based Chemotherapy in Previously Untreated, Unfavourable CUP NCI and CRUK Take on Cancer’s Toughest Problems Tebentafusp Continues to Provide Long-Term OS Benefit in Previously Untreated Patients with Unresectable or Metastatic Uveal Melanoma MOST POPULAR SABCS 2021: New Research and Updates in Breast Cancer Treatment and... January 20, 2022 Combination of Nivolumab and Ipilimumab Yields Better Outcomes Compared to Ipilimumab... September 12, 2023 What is Mindfulness? August 18, 2021 New on NCI’s Websites for September 2023 September 29, 2023 Load more HOT NEWS Progression-Free Survival and Overall Survival Significantly Longer with Lenvatinib Plus Pembrolizumab... Breast Cancer Death Rates Will Rise in Elderly EU Patients but... Adjuvant Pembrolizumab Improves QoL in Patients with High-Risk Resected Melanoma Screening People at High Risk for Pancreatic Cancer May Help Them...
